Found 7 matching trials
CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
PHASE4In Ease Asia clinical trials, P2Y12 inhibitor (ticagrelor or clopidogrel) m...
Location
Affiliated Hospital of Zunyi Medical University
Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
PHASE4Rationale: Heart attacks are a major cause of death and result from coronar...
Location
Aalborg University Hospital
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
PHASE4The aim of this study is to assess the safety and efficacy of the CYP2C19 g...
Location
Samsung Medical Center
The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models
NAThe study purposed to learn how clopidogrel-based antiplatelet treatment fo...
Location
1st University Clinic of the Tbilisi State Medical University
Clopidogrel Monotherapy in Patients With High Bleeding Risk
PHASE4The goal of this research is to show that a shorter duration of two antipla...
Location
Mayo Clinic in Rochester
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
NAThe purpose of this research study is to explore whether genetic testing ca...
Location
University of Alabama at Birmingham
Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy
PHASE4Patients with Chronic Coronary Syndrome (CCS) undergoing with elective perc...
Location
St. Antonius Hospital